Lanchoney T F, Cohen R B, Rocke D M, Zasloff M A, Kaplan F S
Department of Orthopedic Surgery, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
J Pediatr. 1995 May;126(5 Pt 1):762-4. doi: 10.1016/s0022-3476(95)70408-6.
In patients who have fibrodysplasia ossificans progressiva, routine childhood diphtheria-tetanus-pertussis immunizations administered by intramuscular injection caused a significant risk of permanent heterotopic ossification at the site of injection (p < 10(-8)), whereas measles-mumps-rubella immunizations administered by subcutaneous injection posed no significant risk. Intramuscular injections should be avoided, if possible, once a diagnosis of fibrodysplasia ossificans progressiva has been established.
在患有进行性骨化性纤维发育不良的患者中,通过肌肉注射进行的常规儿童白喉-破伤风-百日咳免疫接种在注射部位导致永久性异位骨化的风险显著(p < 10(-8)),而通过皮下注射进行的麻疹-腮腺炎-风疹免疫接种则无显著风险。一旦确诊为进行性骨化性纤维发育不良,应尽可能避免肌肉注射。